Bandingkan Harga & Kinerja Capitalinc Investment Tbk. (MTFN) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Capitalinc Investment Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Capitalinc Investment Tbk. diperdagangkan di Rp13 (kapitalisasi pasar 413,95 M, volume 24 jam 21,34 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb). Perbedaan utamanya: Capitalinc Investment Tbk. jauh lebih besar — sekitar 2,5× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Capitalinc Investment Tbk. lebih aktif diperdagangkan (21,34 jt vs 324 rb). Mana yang lebih baik tergantung tujuan investasimu.
| MTFN | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 413,95 M | 166,01 M |
Volume | 21,34 jt | 324 rb |
Lot | 213,43 rb | 3,24 rb |
Perputaran | — | 77,68 jt |
Harga Rata-rata | — | 239,75 |
Nilai Transaksi | — | 77,68 jt |
Harga Ekuilibrium Indikatif | — | 240 |
Volume Ekuilibrium Indikatif | — | 1 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Capitalinc Investment Tbk.
PT Capitalinc Investment Tbk formerly PT Bakrie Finance Corporation Tbk hereinafter called the Company was established based on deed No.15 dated November 11, 1993 of Notary Soedarno, SH. The deed of establishment was approved by the Minister of Justice of the Republic of Indonesia in his decree No. C2.7999-HT.01.01.Th.83 dated December 12, 1983 and was published in the State Gazette of the Republic of Indonesia No.4 dated January 13, 1984, Supplement No.35.Before the amendment in its articles of association, the scope of its activities include leasing, factoring receivable and consumer financing. The Company obtained its operating license as a financial institution from the Minister of Finance of the Republic of Indonesia through decree No.295/KMK.013/1990 dated March 3, 1990. In line with the change in the Company’s scope of activities, the Company’s financing activities have been transferred to PT Swadinamika Bakrie Finance, a subsidiary.
Selengkapnya di halaman MTFN →Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →
